DRAGO, ANTONIO
DRAGO, ANTONIO
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies
2008 Drago A.; De Ronchi D.; Serretti A.
A genetic dissection of antipsychotic induced movement disorders.
2013 Crisafulli C; Drago A; Sidoti A; Serretti A.
A model to investigate SNPs' interaction in GWAS studies
2015 Cocchi, Enrico; Drago, Antonio; Fabbri, Chiara; Serretti, Alessandro
A molecular pathway analysis informs the genetic background at risk for schizophrenia
2015 Crisafulli, Concetta; Drago, Antonio; Calabrò, Marco; Spina, Edoardo; Serretti, Alessandro
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment.
2013 Drago A; Giegling I; Schäfer M; Hartmann AM; Friedl M; Konte B; Möller HJ; De Ronchi D; Stassen HH; Serretti A; Rujescu D
Alexithymia: phisiopathology, etiology and management
2010 Mori E.; Drago A.; De Ronchi D.; Serretti A.
Association analysis of the Tumor necrosis factor gene polymorphisms (TNFA 238 and 302) in the development of schizophrenia: Impact on the antipsychotic treatment response
2009 Pae C.U.; Drago A.; Chiesa A.; Mandelli L.; Serretti A.; Jun T.Y.
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients
2015 Drago, Antonio; Monti, Barbara; De Ronchi, Diana; Serretti, Alessandro
DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients
2008 Pae C.-U.; Drago A.; Kim J.-J.; Patkar A.A.; Jun T.-Y.; Lee C.; Mandelli L.; De Ronchi D.; Paik I.-H.; Serretti A.
Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR(⁎)D.
2013 Fabbri C; Drago A; Serretti A.
Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder
2008 Yun D.H.; Pae C.U.; Drago A.; Mandelli L.; De Ronchi D.; Patkar A.A.; Paik I.H.; Serretti A.; Kim J.J.
Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder
2015 Antonio, Drago; Concetta, Crisafulli; Marco, Calabrò; Alessandro, Serretti
Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment
2009 Pae C.U.; Drago A.; Patkar A.A.; Jun T.Y.; Serretti A.
Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 Variations Does Not Impact Alcohol Dependence Disorder Features
2009 Drago A.; Liappas I.; Petio C.; Albani D.; Forloni G.; Malitas P.; Piperi C.; Politis A.; Tzavellas E.; Zisaki K.; Prato F.; Batelli S.; Polito L.; De Ronchi D.; Paparrigopoulos T.; Kalofoutis A.; Serretti A.
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
2009 Drago A.; Serretti A.
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.
2014 Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment
2014 Drago, A.; Giegling, I.; Schafer, M.; Hartmann, A.M.; Konte, B.; Friedl, M.; Serretti, A.; Rujescu, D.
Genomewide interaction and enrichment analysis on antidepressant response.
2014 Antypa N; Drago A; Serretti A.
Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol.
2011 Giegling I.; Drago A.; Dolžan V.; Plesnicar B.K.; Schäfer M.; Hartmann A.M.; Sander T.; Toliat M.R.; Möller H.J.; Stassen H.H.; Rujescu D.; Serretti A.
HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory
2010 Drago A; Alboni S; Brunello N; De Ronchi D; Serretti A